Effects of Sufentanil on the Intraoperative Hemodynamics

• Status: Recruiting
• Trial end date: 2025-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Remifentanil; Sufentanil

Criteria

Inclusion Criteria:

• Patients who undergo elective extracranial-intracranial bypass surgery

• American Society of Anesthesiologists grade 1,2,3

• Age > 18 years old

Exclusion Criteria:

• Refuse to participate to the study

• American Society of Anesthesiologists grade 4

• Body Mass Index < 18.5 kg/m2 or > 35 kg/m2

• Allergic history of opioid

• pregnant

• MAO Inhibitor user

• Severe respiratory insufficiency